# ONC201 With a Methionine-Restricted Diet in Patients With Metastatic Triple Negative Breast Cancer

> **NCT03733119** · PHASE2 · TERMINATED · sponsor: **University of Wisconsin, Madison** · enrollment: 4 (actual)

## Conditions studied

- Triple Negative Breast Cancer

## Interventions

- **DRUG:** Akt/ERK Inhibitor ONC201
- **DIETARY_SUPPLEMENT:** Methionine-Restricted Diet

## Key facts

- **NCT ID:** NCT03733119
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-11-13
- **Primary completion:** 2021-02-13
- **Final completion:** 2021-02-13
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Slow accrual
- **Last updated:** 2022-03-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03733119

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03733119, "ONC201 With a Methionine-Restricted Diet in Patients With Metastatic Triple Negative Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03733119. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*